Babahosseini Hesam, Ketene Alperen N, Schmelz Eva M, Roberts Paul C, Agah Masoud
Department of Mechanical Engineering, Virginia Tech, Blacksburg, VA, USA; VT MEMS Laboratory, The Bradley Department of Electrical and Computer Engineering, Virginia Tech, Blacksburg, VA, USA.
Department of Human Nutrition, Foods & Exercise, Virginia Tech, Blacksburg, VA, USA.
Nanomedicine. 2014 Jul;10(5):1013-9. doi: 10.1016/j.nano.2013.12.009. Epub 2014 Jan 6.
We herein report, for the first time, the mechanical properties of ovarian cancer stem-like/tumor-initiating cells (CSC/TICs). The represented model is a spontaneously transformed murine ovarian surface epithelial (MOSE) cell line that mimics the progression of ovarian cancer from early/non-tumorigenic to late/highly aggressive cancer stages. Elastic modulus measurements via atomic force microscopy (AFM) illustrate that the enriched CSC/TICs population (0.32±0.12kPa) are 46%, 61%, and 72% softer (P<0.0001) than their aggressive late-stage, intermediate, and non-malignant early-stage cancer cells, respectively. Exposure to sphingosine, an anti-cancer agent, induced an increase in the elastic moduli of CSC/TICs by more than 46% (0.47±0.14kPa, P<0.0001). Altogether, our data demonstrate that the elastic modulus profile of CSC/TICs is unique and responsive to anti-cancer treatment strategies that impact the cytoskeleton architecture of cells. These findings increase the chance for obtaining distinctive cell biomechanical profiles with the intent of providing a means for effective cancer detection and treatment control.
This novel study utilized atomic force microscopy to demonstrate that the elastic modulus profile of cancer stem cell-like tumor initiating cells is unique and responsive to anti-cancer treatment strategies that impact the cytoskeleton of these cells. These findings pave the way to the development of unique means for effective cancer detection and treatment control.
我们在此首次报告卵巢癌干细胞样/肿瘤起始细胞(CSC/TICs)的力学特性。所展示的模型是一种自发转化的小鼠卵巢表面上皮(MOSE)细胞系,它模拟了卵巢癌从早期/非致瘤阶段到晚期/高度侵袭性癌阶段的进展过程。通过原子力显微镜(AFM)进行的弹性模量测量表明,富集的CSC/TICs群体(0.32±0.12千帕)分别比其侵袭性晚期、中期和非恶性早期癌细胞软46%、61%和72%(P<0.0001)。接触抗癌剂鞘氨醇可使CSC/TICs的弹性模量增加超过46%(0.47±0.14千帕,P<0.0001)。总之,我们的数据表明,CSC/TICs的弹性模量特征是独特的,并且对抗癌治疗策略有反应,这些策略会影响细胞的细胞骨架结构。这些发现增加了获得独特细胞生物力学特征的机会,旨在提供一种有效的癌症检测和治疗控制手段。
这项新颖的研究利用原子力显微镜证明,癌症干细胞样肿瘤起始细胞的弹性模量特征是独特的,并且对抗癌治疗策略有反应,这些策略会影响这些细胞的细胞骨架。这些发现为开发有效的癌症检测和治疗控制的独特方法铺平了道路。